Nurexone Biologic Inc (NRXBF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,510 | 2,373 | 983 | 1,228 | 588 |
| Marketable Securities | 44 | 44 | 41 | 41 | 41 |
| Receivables | 153 | 184 | 122 | 84 | 135 |
| TOTAL | $1,707 | $2,601 | $1,146 | $1,953 | $1,364 |
| Non-Current Assets | |||||
| PPE Net | 721 | 757 | 764 | 778 | 740 |
| Other Non-Current Assets | 719 | 725 | 736 | 133 | 36 |
| TOTAL | $1,440 | $1,482 | $1,500 | $911 | $776 |
| Total Assets | $3,147 | $4,083 | $2,646 | $2,864 | $2,140 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 310 | 348 | 496 | 678 | 366 |
| Accrued Expenses | 454 | 406 | 366 | 329 | 187 |
| Other current liabilities | N/A | 235 | N/A | N/A | N/A |
| TOTAL | $764 | $989 | $862 | $1,007 | $553 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 381 | 336 | 327 | 325 | 271 |
| TOTAL | $381 | $336 | $327 | $325 | $271 |
| Total Liabilities | $1,145 | $1,325 | $1,189 | $1,332 | $824 |
| Shareholders' Equity | |||||
| Retained earnings | -27,250 | -25,484 | -24,089 | -22,624 | -20,778 |
| Other shareholders' equity | 2,469 | 2,150 | 1,723 | 1,403 | 1,681 |
| TOTAL | $2,002 | $2,758 | $1,457 | $1,532 | $1,316 |
| Total Liabilities And Equity | $3,147 | $4,083 | $2,646 | $2,864 | $2,140 |